Amgen Adds To Sutro Biopharma Investment
socalTECH
JULY 30, 2018
Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. in a Series E funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M
Let's personalize your content